Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials-Reference-Cited by-同舟云学术

Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials

Published:2014-03 Issue:3 Volume:167 Page:401-412.e6
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Tarantini Giuseppe,Brener Sorin Jakob,Barioli Alberto,Gratta Andrea,Parodi Guido,Rossini Roberta,Navarese Eliano Pio,Niccoli Giampaolo,Frigo Anna Chiara,Musumeci Giuseppe,Iliceto Sabino,Stone Gregg Whitney

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Bivalirudin versus heparin during angioplasty for unstable or postinfarction angina: final report reanalysis of the Bivalirudin Angioplasty Study;Bittl;Am Heart J,2001

2. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial);Lincoff;Am J Cardiol,2004

3. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial;Lincoff;JAMA,2003

4. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial;Stone;Lancet,2007

5. Bivalirudin versus unfractionated heparin during percutaneous intervention;Kastrati;N Eng J Med,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Patients treated with bivalirudin are still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomised clinical trials of bivalirudin and heparin for percutaneous coronary interventions;Kardiologia Polska;2018-04-10

3. Impact of time to treatment on the effects of bivalirudin vs. glycoprotein IIb/IIIa inhibitors and heparin in patients undergoing primary percutaneous coronary intervention: insights from the HORIZONS-AMI trial;EuroIntervention;2016-10

4. Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses;Journal of Thoracic Disease;2016-09

5. Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications;American Journal of Cardiovascular Drugs;2016-08-19